JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Porter, C. C.
Right arrow Articles by Burcin, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Porter, C. C.
Right arrow Articles by Burcin, A.
Journal of Pharmacology And Experimental Therapeutics, Vol. 150, Issue 1, 17-22, 1965
Copyright © 1965 by American Society for Pharmacology and Experimental Therapeutics


THE RELATIONSHIP BETWEEN RADIOACTIVITY AND NOREPINEPHRINE CONCENTRATIONS IN THE BRAINS AND HEARTS OF MICE FOLLOWING ADMINISTRATION OF LABELED METHYLDOPA OR 6-HYDROXYDOPAMINE

Curt C. Porter 1, James A. Totaro 1, and Andre Burcin 1

1 Merck Institute for Therapeutic Research, West Point, Pennsylvania

After the administration of 2-C14-methyldopa to mice, both the brains and the hearts contained radioactivity which disappeared with time, but not completely until tissue norepinephrine concentrations had returned to essentially normal values. Extracts of the tissues contained a radioactive substance which on paper traveled with the same Rf as agr-methylnorepinephrine. Brain extracts contained, in addition, radioactivity which traveled with the Rf of methyldopa or methyldopamine, and which was an amine as shown by ion exchange chromatography. Reserpine (10 mg/kg) had no effect upon radioactivity in brain; however, it removed about 60% of the radioactivity in the heart. The ED5O of reserpine in depleting time heart of the labile radioactivity was about 10 times as large as its ED5O in depleting the heart of norepinephrine. It is concluded that agr-methylnorepinephrine, formed in the metabolism of administered methyldopa, displaced norepinephrine molecule for molecule, and that, conversely, with time norepinephrine displaced agr-methylnorepinephrine in the same way.

The administration of 2-C14-6-hydroxydopamine was followed by an accumulation of radioactivity in the heart which was reciprocally related to heart norepinephrine over the entire course of the experiment (44 days). It seems probable that 6-hydroxydopamine, or a metabolite, displaced norepinephrine molecule for molecule.

Accepted on May 12, 1965







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1965 by the American Society for Pharmacology and Experimental Therapeutics.